BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24606512)

  • 1. Editorial: cardiovascular drug therapy in paediatric age: from metabolomics to clinical practice.
    Bassareo PP; Fanos V
    Curr Med Chem; 2014; 21(27):3107. PubMed ID: 24606512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
    Ohlsson A; Shah PS
    Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants.
    Jones LJ; Craven PD; Attia J; Thakkinstian A; Wright I
    Arch Dis Child Fetal Neonatal Ed; 2011 Jan; 96(1):F45-52. PubMed ID: 20876595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular malformations among preterm infants.
    Tanner K; Sabrine N; Wren C
    Pediatrics; 2005 Dec; 116(6):e833-8. PubMed ID: 16322141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support.
    American Heart Association
    Pediatrics; 2006 May; 117(5):e989-1004. PubMed ID: 16651298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal heart programming: long-term consequences.
    Faa A; Ambu R; Faa G; Fanos V
    Curr Med Chem; 2014; 21(27):3165-72. PubMed ID: 24606508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
    Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.
    Fowlie PW; Davis PG
    Cochrane Database Syst Rev; 2002; (3):CD000174. PubMed ID: 12137607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.
    Chiang CE; Wang TD; Ueng KC; Lin TH; Yeh HI; Chen CY; Wu YJ; Tsai WC; Chao TH; Chen CH; Chu PH; Chao CL; Liu PY; Sung SH; Cheng HM; Wang KL; Li YH; Chiang FT; Chen JH; Chen WJ; Yeh SJ; Lin SJ
    J Chin Med Assoc; 2015 Jan; 78(1):1-47. PubMed ID: 25547819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.